NIH Stock Overview
Network International Holdings plc operates as a digital commerce enabler in the Middle East and Africa.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Network International Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£4.58 |
| 52 Week High | UK£4.62 |
| 52 Week Low | UK£3.98 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 5.05% |
| 3 Year Change | -2.14% |
| 5 Year Change | -24.91% |
| Change since IPO | -21.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIH | DE Diversified Financial | DE Market | |
|---|---|---|---|
| 7D | -0.6% | 3.7% | 1.8% |
| 1Y | 5.0% | -6.9% | 2.2% |
Return vs Industry: NIH exceeded the German Diversified Financial industry which returned -6.9% over the past year.
Return vs Market: NIH exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| NIH volatility | |
|---|---|
| NIH Average Weekly Movement | 0.9% |
| Diversified Financial Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NIH has not had significant price volatility in the past 3 months.
Volatility Over Time: NIH's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 2,133 | Nandan Mer | www.network.ae |
Network International Holdings plc operates as a digital commerce enabler in the Middle East and Africa. The company provides technology-enabled payment solutions to merchants and financial institutions. It also offers merchant solutions comprise payment solutions, such as N-genius payment device, N-genius mobile app, mobility, and unattended solutions; and N-Genius online, and Payfast and DPO pay online payment solutions.
Network International Holdings plc Fundamentals Summary
| NIH fundamental statistics | |
|---|---|
| Market cap | €2.44b |
| Earnings (TTM) | €61.38m |
| Revenue (TTM) | €457.98m |
39.8x
P/E Ratio5.3x
P/S RatioIs NIH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIH income statement (TTM) | |
|---|---|
| Revenue | US$490.13m |
| Cost of Revenue | US$144.11m |
| Gross Profit | US$346.03m |
| Other Expenses | US$280.34m |
| Earnings | US$65.69m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 70.60% |
| Net Profit Margin | 13.40% |
| Debt/Equity Ratio | 68.4% |
How did NIH perform over the long term?
See historical performance and comparison